IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.
about
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapyNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsIL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance.A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursInduction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.MicroRNAs and STAT interplay.Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitisNitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infectionDendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors.GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.Naringenin inhibits osteoclastogenesis through modulation of helper T cells-secreted IL-4.Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas.
P2860
Q21245464-A382EF58-8B87-4B3E-A6A3-CAF90188F250Q28078299-762EDCCB-F0FC-4A05-A2D3-4088FB60941DQ31131991-B18E2E56-512D-46CA-91C6-2D027D519D63Q34682173-8AF0AFA8-A22A-4009-BA45-EAC272A89BDDQ34744875-67855373-CE03-4DA1-BBBC-270AE0298CEAQ34979511-1C2C0E9C-1248-46FC-B29C-3B0AE5BD3A70Q35785559-1093BE55-FA29-445E-A827-7761006143B0Q35957449-55D3645E-F7C7-49B5-879C-82C1C3E3F15FQ36875493-7E6C4080-230D-4BD3-967F-B83357C7482AQ38176625-11EA32BD-C06C-4AE0-AB65-7F2CB5B11843Q38873974-AF1E21E4-1E01-4F30-B0B8-B53A3571F067Q39817335-AFBCFD9F-1B10-4F09-8D76-E628118CE772Q41870476-FDD88538-534C-4A73-B8A9-3C2BBACD3591Q47915117-7D5274EC-8A21-4ABB-A231-766D95544C84Q55070663-20195926-41CD-4277-AD2B-DCCA5CECC57D
P2860
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@en
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@nl
type
label
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@en
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@nl
prefLabel
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@en
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@nl
P2093
P2860
P1476
IL-4 suppresses very late anti ...... -cell trafficking into tumors.
@en
P2093
Angela D Pardee
Gary Kohanbash
Hideho Okada
Kotaro Sasaki
Lisa M Bailey
Louis D Falo
Pawel Kalinski
Per H Basse
Ravikumar Muthuswamy
P2860
P304
P356
10.1097/CJI.0B013E3181ACEC1E
P577
2009-10-01T00:00:00Z